⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GCTK News
GlucoTrack, Inc. Common Stock
Form 8-K/A
sec.gov
GCTK
Form 8-K
sec.gov
GCTK
E.F. Hutton & Co. Serves as Exclusive Financial Advisor on Strategic Business Combination Between Glucotrack and Lōkahi Therapeutics and Exclusive Placement Agent for Approximately $5.7 Million Convertible Note Financing
globenewswire.com
GCTK
Glucotrack, Inc. and Lōkahi Therapeutics™ Announce Strategic Financing Support from E.F. Hutton & Co. in Connection with Their Recently Completed Business Combination and Future Capital Markets Initiatives
globenewswire.com
GCTK
UPDATE – Glucotrack and Lōkahi Therapeutics Complete Strategic Business Combination, Establishing Lōkahi-Controlled Public Platform
globenewswire.com
GCTK
Form 8-K
sec.gov
GCTK
Glucotrack and Lōkahi Therapeutics Complete Strategic Business Combination, Establishing Lōkahi-Controlled Public Platform
globenewswire.com
GCTK
Glucotrack Announces USPTO Notice of Allowance for Patent Application Covering Its Implantable CBGM Platform
globenewswire.com
GCTK
Glucotrack to Highlight Implantable Continuous Blood Glucose Monitoring Technology at the American Diabetes Association’s 2026 Scientific Sessions
globenewswire.com
GCTK
Form 8-K
sec.gov
GCTK